Compare TUSK & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TUSK | TMCI |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.2M | 120.4M |
| IPO Year | 2016 | 2021 |
| Metric | TUSK | TMCI |
|---|---|---|
| Price | $2.46 | $1.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 330.6K | ★ 766.5K |
| Earning Date | 03-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.32 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | $44,292,000.00 | ★ $212,690,000.00 |
| Revenue This Year | $383.90 | N/A |
| Revenue Next Year | N/A | $7.65 |
| P/E Ratio | $26.20 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $1.68 | $1.17 |
| 52 Week High | $2.96 | $8.35 |
| Indicator | TUSK | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 38.54 |
| Support Level | $2.13 | N/A |
| Resistance Level | $2.50 | $3.01 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 48.58 | 38.24 |
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.